Immune cell activation inhibitor and use thereof
US9517217B2 · kind B2 · utility
0Cited by
1References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 2, 2013 |
| Grant date | Dec 13, 2016 |
| Priority date | — |
| Expiry date | Aug 2, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a pharmaceutical that can be used widely for intractable neurological diseases, inflammatory diseases, etc. The immune cell activation inhibitor of the present invention contains bromovalerylurea or a derivative thereof. The immune cell activation inhibitor of the present invention can be used as a pharmaceutical for, for example: chronic neurological diseases such as Parkinson's disease and Alzheimer's disease; acute neurological diseases such as cerebral infarction and brain injury; and inflammatory diseases such as systemic inflammatory response syndromes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.